Skip to main content
IDEX Biometrics ASA logo

IDEX Biometrics ASA — Investor Relations & Filings

Ticker · IDEX ISIN · NO0013107490 LEI · 5967007LIEEXZXHECW11 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,321 across all filing types
Latest filing 2025-03-11 Capital/Financing Update
Country NO Norway
Listing OL IDEX

About IDEX Biometrics ASA

https://www.idexbiometrics.com/

IDEX Biometrics ASA is a technology company specializing in fingerprint identification and biometric authentication solutions. The company designs, develops, and commercializes proprietary fingerprint sensors and software for integration into smart cards. Its core products are biometric payment cards and access cards, which provide enhanced security for financial transactions and identity verification. The technology stores and matches the user's fingerprint data directly on the card, ensuring that sensitive biometric information is never stored in the cloud. This on-card approach enables secure and convenient authentication with a simple touch, replacing traditional PINs and passwords. The solutions are certified by major payment networks like Visa and Mastercard and are compliant with FIDO standards for strong online authentication, offering protection against phishing and other cyber threats for both payment and access control systems.

Recent filings

Filing Released Lang Actions
IDEX Biometrics ASA - Key information relating to possible subsequent offering/repair offering
Capital/Financing Update Classification · 98% confidence The document explicitly discusses a 'possible subsequent offering/repair offering' involving the issuance of new shares (up to 600,000,000) at a specific subscription price (NOK 0.01). It details key dates related to this offering (Ex-date, Record date) and mentions that the offering is subject to approval by an Extraordinary General Meeting. This content directly relates to fundraising, capital structure changes, and the issuance of new shares. This aligns best with the 'Capital/Financing Update' (CAP) definition, as it details a planned capital raise. While it mentions an EGM, the primary focus is the financing mechanism itself, not the voting results (DVA) or the AGM presentation (AGM-R). It is not a full report, so RPA/RNS is less specific than CAP.
2025-03-11 English
IDEX Biometrics ASA: Loan financing of NOK 30 million secured; proposed debt conversion; amendment of Convertible Bond
Capital/Financing Update Classification · 98% confidence The document is an announcement from IDEX Biometrics ASA dated March 11, 2025, detailing several significant financial and corporate actions: securing NOK 30 million in loan financing, proposing a debt conversion into shares, proposing a share capital decrease, planning a subsequent equity offering, and proposing amendments to an existing convertible bond. These actions relate directly to the company's capital structure, financing, and debt management. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes specific, material financing events.
2025-03-11 English
IDEX BIOMETRICS ASA REVISES ITS BUSINESS STRATEGY PLAN AND MAKES CHANGES IN MANAGEMENT
Management Reports Classification · 99% confidence The document explicitly announces a revision of the business strategy plan and significant changes in senior management (CEO stepping down, new CEO appointed). This content directly aligns with the definition of Board/Management Information (MANG). Although it discusses strategy, the primary focus and headline are the management changes following a strategic review. It is not a full financial report (10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2025-03-11 English
IDEX BIOMETRICS ASA REVISES ITS BUSINESS STRATEGY PLAN AND MAKES CHANGES IN MANAGEMENT
Board/Management Information Classification · 99% confidence The document explicitly announces a revision of the business strategy plan and significant changes in senior management (CEO stepping down, new CEO appointed). This content directly aligns with the definition of Board/Management Information (MANG). Although it discusses strategy, the primary focus and headline are the management changes following a strategic review. It is not a full financial report (10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2025-03-11 English
IDEX Biometrics receives purchase order for biometric payment cards to Japan
Regulatory Filings Classification · 99% confidence The document is a short press release announcing a specific business event: receiving a production order for biometric payment cards in Japan. It contains key details like the order value (USD 50,000), the partner (BCC), and the market (Japan). It is not a comprehensive financial report (like 10-K or IR), nor is it a transcript, management discussion, or formal voting result. It is a specific operational/business update that relates to sales and contracts. Since there is no specific category for 'Business Update' or 'Contract Award', and it is not a standard regulatory filing like insider trading (DIRS) or major shareholding (MRQ), the most appropriate fallback category is 'Regulatory Filings' (RNS), as it is a formal announcement disclosed under EU Market Abuse Regulation and Norwegian Securities Trading Act, intended for the market.
2025-03-04 English
IDEX Biometrics ASA - Information about the first exercise period for warrants (Warrants A) issued in connection with the Private Placement and Subsequent Offering
Capital/Financing Update Classification · 98% confidence The document is titled "IDEX BIOMETRICS ASA EXERCISE OF WARRANTS A" and is explicitly labeled as an "EXERCISE FORM". It details the procedure, terms, exercise price (NOK 0.15), and deadlines for exercising Warrants A to subscribe for new shares. This document relates directly to a capital structure change involving the issuance of new shares via warrant exercise, which falls under the category of financing activities or capital structure changes. This aligns best with the 'Capital/Financing Update' (CAP) definition, as it is the mechanism for executing a previously authorized capital increase. While it relates to a resolution from an Extraordinary General Meeting (EGM), the document itself is the transactional form for capital raising, not the meeting minutes or voting results.
2025-02-28 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.